We are live on ! Find out more

510 hedge funds and large institutions have $9.23B invested in Chemed in 2024 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 166 increasing their positions, 187 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more call options, than puts

Call options by funds: $4.37M | Put options by funds: $2.05M

25% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 53

7% more capital invested

Capital invested by funds: $8.66B → $9.23B (+$566M)

2% more funds holding

Funds holding: 500510 (+10)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

3.27% less ownership

Funds ownership: 98.38%95.11% (-3.3%)

11% less repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 187

Holders
510
Holders Change
+10
Holders Change %
+2%
% of All Funds
7.35%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
66
Increased
166
Reduced
187
Closed
53
Calls
$4.37M
Puts
$2.05M
Net Calls
+$2.31M
Net Calls Change
-$2.31M
Name Holding Trade Value Shares
Change
Change in
Stake
MDSL
51
M.D. Sass LLC
New York
$32.8M -$3.59M -5,905 -10%
ProShare Advisors
52
ProShare Advisors
Maryland
$32.5M +$30.3M +49,808 +6,289%
JAM
53
Jupiter Asset Management
United Kingdom
$31.9M -$15.8K -26 -0.1%
Goldman Sachs
54
Goldman Sachs
New York
$30.9M -$3.16M -5,204 -10%
Qube Research & Technologies (QRT)
55
Qube Research & Technologies (QRT)
United Kingdom
$28.4M +$6.08M +10,009 +29%
Retirement Systems of Alabama
56
Retirement Systems of Alabama
Alabama
$27.4M +$30.4K +50 +0.1%
Capital World Investors
57
Capital World Investors
California
$27M
Rockefeller Capital Management
58
Rockefeller Capital Management
New York
$26.9M -$3.02M -4,970 -11%
Los Angeles Capital Management
59
Los Angeles Capital Management
California
$26.8M +$25.3M +41,712 New
SEI Investments
60
SEI Investments
Pennsylvania
$26.5M +$1.08M +1,780 +4%
MAM
61
Martingale Asset Management
Massachusetts
$25.1M -$1.86M -3,069 -7%
MWM
62
Moran Wealth Management
Florida
$24.4M -$587K -967 -2%
ACA
63
Aptus Capital Advisors
Alabama
$24.3M +$2.09M +3,438 +10%
Pictet Asset Management
64
Pictet Asset Management
Switzerland
$24M -$9.62M -15,832 -30%
Royal Bank of Canada
65
Royal Bank of Canada
Ontario, Canada
$23.1M -$4.44M -7,310 -17%
N
66
Nuveen
North Carolina
$22.9M -$423K -697 -2%
Legal & General Group
67
Legal & General Group
United Kingdom
$21.5M -$1.13M -1,855 -5%
BIM
68
Bridges Investment Management
Nebraska
$21.4M -$754K -1,241 -4%
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$20.9M -$4.46M -7,340 -18%
Loomis, Sayles & Company
70
Loomis, Sayles & Company
Massachusetts
$18.8M -$131K -215 -0.7%
UBS Group
71
UBS Group
Switzerland
$18.8M -$996K -1,640 -5%
Thrivent Financial for Lutherans
72
Thrivent Financial for Lutherans
Minnesota
$18.7M +$15.4M +25,360 +674%
Swiss National Bank
73
Swiss National Bank
Switzerland
$18.1M
First Trust Advisors
74
First Trust Advisors
Illinois
$17.8M +$5.6M +9,221 +50%
GF
75
Gabelli Funds
New York
$17.6M -$63.8K -105 -0.4%

CHE Hedge Fund Activity: Q1 2024 in Review

510 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q1 2024, worth a combined $9.23B — up 6.5% from $8.66B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new CHE positions and 53 closed out — a net gain of 13 holders — while 166 added to existing stakes and 187 trimmed.

The largest buyer was Durable Capital Partners, adding an estimated $39.4M. The largest seller was Morgan Stanley, cutting an estimated $249M.

  • 510 institutional investors held Chemed (CHE) as of Q1 2024, up from 500 in Q4 2023.
  • Funds reported $9.23B of Chemed stock for Q1 2024, up 6.5% quarter-over-quarter.
  • 66 funds opened new Chemed positions in Q1 2024 and 53 closed out, a net change of +13 holders.
  • The largest Chemed buyer in Q1 2024 was Durable Capital Partners, an estimated $39.4M added.
  • The largest Chemed seller in Q1 2024 was Morgan Stanley, an estimated $249M sold.

Based on aggregated 13F filings for Q1 2024.